How are vasculitides classified according to vessel size and primary versus secondary causes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Classification of Vasculitis

Vasculitides are classified primarily by the size of the predominant vessel involved (small, medium, or large) and secondarily by whether they are primary (idiopathic) or secondary to other conditions such as infections, drugs, autoimmune diseases, or malignancies. 1, 2

Classification by Vessel Size

Large Vessel Vasculitis

  • Large vessels refer to the aorta and its major branches 3
  • The primary forms include:
    • Giant cell arteritis (GCA) 1, 3
    • Takayasu arteritis (TAK) 1, 3
  • Isolated aortitis represents a single-organ variant 3

Medium Vessel Vasculitis

  • Medium vessels refer to the main visceral arteries and veins and their initial branches 3
  • The primary forms include:
    • Polyarteritis nodosa (PAN) 1, 4
    • Kawasaki disease 4, 3

Small Vessel Vasculitis

  • Small vessels include arterioles, capillaries, and venules 1
  • This category is further subdivided into:

ANCA-Associated Vasculitides (AAV):

  • Granulomatosis with polyangiitis (formerly Wegener granulomatosis) 1, 5, 6
  • Microscopic polyangiitis (MPA) 1, 5, 6
  • Eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome) 1, 6

Non-ANCA-Associated (Immune Complex-Mediated) Small Vessel Vasculitides:

  • IgA vasculitis (Henoch-Schönlein purpura) - most common in children 2, 4
  • Cryoglobulinemic vasculitis 1, 4
  • Cutaneous leukocytoclastic angiitis - most common in adults 2, 4

Classification by Primary vs. Secondary Causes

Primary Vasculitides

  • These are idiopathic systemic vasculitides without an identifiable underlying cause 4
  • Approximately 50% of cutaneous vasculitis cases remain etiologically unexplained 2
  • Classification is based on immunopathological features and vessel size involved 4

Secondary Vasculitides

Infectious triggers:

  • Hepatitis B-associated polyarteritis nodosa 1
  • Hepatitis C-associated cryoglobulinemic vasculitis 1
  • Other viral, bacterial, or fungal infections 2

Drug-induced vasculitis 2

Vasculitis associated with autoimmune diseases (e.g., systemic lupus erythematosus, rheumatoid arthritis) 2

Malignancy-associated vasculitis 2

Important Clinical Considerations

Overlap Between Categories

  • There is substantial overlap in vessel size involvement, and arteries of any size can potentially be affected in any of the three main categories 3, 7
  • This overlap creates challenges for rigid classification schemes 7

Distinguishing Vasculitis from Vasculopathy

  • It is critical to differentiate true vasculitides (inflammatory vessel disease) from vasculopathies (non-inflammatory vessel disorders), as they can manifest similarly but require different management 2

Additional Classification Features

Beyond vessel size, vasculitides can be characterized by:

  • Presence or absence of granulomatous inflammation 4, 7
  • Association with specific autoantibodies (particularly ANCA) 4, 5
  • Demographic features and organ tropism 7
  • Role of immune complexes in pathophysiology 4, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Cutaneous Vasculitides - Clinical Manifestations, Diagnosis, and Aetiology].

Therapeutische Umschau. Revue therapeutique, 2022

Research

Medium- and Large-Vessel Vasculitis.

Circulation, 2021

Research

Advances in the treatment of ANCA-associated vasculitis.

Nature reviews. Rheumatology, 2025

Research

Classification and diagnostic criteria in systemic vasculitis.

Best practice & research. Clinical rheumatology, 2005

Related Questions

What is the appropriate evaluation and management for a 12-year-old female with a one-year history of painless bilateral axillary lymphadenopathy and no other symptoms?
How should a 15-year-old female with recurrent presyncope, tunnel vision, vomiting episodes, and recent headache, and no significant past medical history, be evaluated and managed?
What is the body mass index (BMI) for a person who is 165 cm tall and weighs 84 kg?
In an 18-year-old female who experienced bleeding and pain after a vaginal swab performed yesterday, should these symptoms be expected to be self‑limiting?
What full‑time spectacle prescription should be given for a patient with a refraction of +2.25 – 1.75 × 135 in the right eye (OD) and +2.50 – 1.25 × 125 in the left eye (OS), with no near addition (ADD 0.00 D)?
What does a low transferrin saturation indicate?
Should we give a second full course of flucloxacillin (flucloxacillin) before MRI (magnetic resonance imaging) for suspected osteomyelitis in a patient with nine‑week foot swelling that has not resolved with gout treatment, prednisolone, and a one‑week trial of flucloxacillin?
What is the recommended isolation period for a patient with varicella (chickenpox)?
What are the optimal Helix fractional CO₂ laser settings for treating acne scarring in an adult patient with Fitzpatrick skin type I‑III, no active acne, no isotretinoin use in the past six months, and no history of keloid formation?
A patient allergic to trimethoprim‑sulfamethoxazole (Bactrim), doxycycline, levofloxacin, ciprofloxacin, and other sulfonamides has an uncomplicated urinary tract infection; which antibiotics can be safely used?
In a patient on insulin glargine 15 U at bedtime and rapid‑acting insulin 5 U before breakfast, lunch, and dinner, how can I assess the effectiveness of the prandial insulin and adjust its dose?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.